LYKALABS
Lyka Labs Limited
Pharmaceuticals
Share price
₹75
Market cap
₹271 Cr
1Y return
▼ 21%
A pharmaceutical manufacturer engaged in developing, producing, and marketing finished dosage formulations across multiple therapeutic areas. Incorporated in 1976, the company focuses on quality manufacturing and distribution of pharmaceutical products to meet domestic healthcare needs. Lyka Labs operates as a vertically integrated player in India's pharmaceutical sector, serving patients and healthcare providers through its diversified portfolio of generic and branded medications across various treatment segments.
Recent moves 2
Mr. Kunal Gandhi
29 Jun 2026. Sign in to see this move
4 promotersIncreased
Four promoters of Lyka Labs Limited bought 55,967 shares for ₹39 lakh at ₹69.85 apiece, increasing their holding from 57,01,000 to 57,56,967 shares through the open market.
Read more
Track the whales in Lyka Labs Limited
Get alerted the moment a top investor buys or sells.
Get started